Cargando…
The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS:...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843563/ https://www.ncbi.nlm.nih.gov/pubmed/36660119 http://dx.doi.org/10.4103/2211-5056.361975 |
_version_ | 1784870437660917760 |
---|---|
author | Jain, Manish Garg, Sunir J. Khan, Mohammad Chaudhary, Varun Zeraatkar, Dena Kurian, Dhanya Lal, Sarath |
author_facet | Jain, Manish Garg, Sunir J. Khan, Mohammad Chaudhary, Varun Zeraatkar, Dena Kurian, Dhanya Lal, Sarath |
author_sort | Jain, Manish |
collection | PubMed |
description | PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC. |
format | Online Article Text |
id | pubmed-9843563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-98435632023-01-18 The associations between central serous chorioretinopathy and muscle relaxants: A case–control study Jain, Manish Garg, Sunir J. Khan, Mohammad Chaudhary, Varun Zeraatkar, Dena Kurian, Dhanya Lal, Sarath Taiwan J Ophthalmol Original Article PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC. Wolters Kluwer - Medknow 2022-11-28 /pmc/articles/PMC9843563/ /pubmed/36660119 http://dx.doi.org/10.4103/2211-5056.361975 Text en Copyright: © 2022 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Jain, Manish Garg, Sunir J. Khan, Mohammad Chaudhary, Varun Zeraatkar, Dena Kurian, Dhanya Lal, Sarath The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title | The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title_full | The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title_fullStr | The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title_full_unstemmed | The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title_short | The associations between central serous chorioretinopathy and muscle relaxants: A case–control study |
title_sort | associations between central serous chorioretinopathy and muscle relaxants: a case–control study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843563/ https://www.ncbi.nlm.nih.gov/pubmed/36660119 http://dx.doi.org/10.4103/2211-5056.361975 |
work_keys_str_mv | AT jainmanish theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT gargsunirj theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT khanmohammad theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT chaudharyvarun theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT zeraatkardena theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT kuriandhanya theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT lalsarath theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT jainmanish associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT gargsunirj associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT khanmohammad associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT chaudharyvarun associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT zeraatkardena associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT kuriandhanya associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy AT lalsarath associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy |